Centricity Research Columbus Endocrinology — Columbus, Georgia

Centricity Research Columbus Endocrinology is a clinical research site located in Columbus, Georgia, United States 31904.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Centricity Research Columbus Endocrinology has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Peripheral Neuropathic Pain, Type 2 Diabetes, Type 2 Diabetes Mellitus.

Sponsors: Reata, a wholly owned subsidiary of Biogen, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Centricity Research Columbus Endocrinology?

Centricity Research Columbus Endocrinology has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Centricity Research Columbus Endocrinology conducted?

Centricity Research Columbus Endocrinology has 3 clinical trials on record, with 1 currently active. Their work covers Diabetic Peripheral Neuropathic Pain, Type 2 Diabetes, Type 2 Diabetes Mellitus.

Is Centricity Research Columbus Endocrinology accredited by Crixeo Health?

Centricity Research Columbus Endocrinology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Centricity Research Columbus Endocrinology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.